Department of Gynaecology and Obstetrics, Holbaek Hospital, Holbaek, Denmark.
J Cell Mol Med. 2012 Dec;16(12):3001-8. doi: 10.1111/j.1582-4934.2012.01627.x.
Small-conductance calcium-activated potassium (SK3) channels have been detected in human myometrium and we have previously shown a functional role of SK channels in human myometrium in vitro. The aims of this study were to identify the precise localization of SK3 channels and to quantify SK3 mRNA expression in myometrium from pregnant and non-pregnant women. Myometrial biopsies were obtained from pregnant (n = 11) and non-pregnant (n = 11) women. The expression of SK3 channels was assessed using immunohistochemistry and SK3 mRNA was determined by qRT-PCR. In non-pregnant myometrium SK3 immunoreactivity was observed in CD34 positive (CD34(+)) interstitial Cajal-like cells (ICLC), now called telocytes. Although CD34(+) cells were also present in pregnant myometrium, they lacked SK3 immunoreactivity. Furthermore, the immunohistochemical results showed that SK3 expression in vascular endothelium was similar between the two groups. CD117 immunoreactivity was only detected in small round cells that resemble mast cells. Compared to non-pregnant myometrium we found significantly less SK3 mRNA in pregnant myometrium. We demonstrate that SK3 channels are localized solely in CD34(+) cells and not in smooth muscle cells, and that the molecular expression of SK3 channels is higher in non-pregnant compared to pregnant myometrium. On the basis of our previous study and the present findings, we propose that SK3 activators reduce contractility in human myometrium by modulating telocyte function. This is the first report to provide evidence for a possible role of SK3 channels in human uterine telocytes.
小电导钙激活钾 (SK3) 通道已在人子宫平滑肌中被检测到,我们之前已经证明 SK 通道在人子宫平滑肌中的功能作用在体外。本研究的目的是确定 SK3 通道的精确定位,并定量检测妊娠和非妊娠妇女子宫平滑肌中的 SK3 mRNA 表达。从妊娠(n = 11)和非妊娠(n = 11)妇女中获得子宫平滑肌活检。使用免疫组织化学评估 SK3 通道的表达,并通过 qRT-PCR 确定 SK3 mRNA。在非妊娠子宫平滑肌中,SK3 免疫反应性观察到在 CD34 阳性(CD34(+))间质 Cajal 样细胞(ICLC)中,现在称为 telocytes。尽管 CD34(+)细胞也存在于妊娠子宫平滑肌中,但它们缺乏 SK3 免疫反应性。此外,免疫组织化学结果表明,两组之间血管内皮细胞中的 SK3 表达相似。CD117 免疫反应性仅在类似于肥大细胞的小圆细胞中检测到。与非妊娠子宫平滑肌相比,我们发现妊娠子宫平滑肌中的 SK3 mRNA 明显减少。我们证明 SK3 通道仅定位于 CD34(+)细胞而不是平滑肌细胞,并且非妊娠子宫平滑肌中的 SK3 通道分子表达高于妊娠子宫平滑肌。基于我们之前的研究和本研究结果,我们提出 SK3 激活剂通过调节 telocyte 功能来降低人子宫平滑肌的收缩性。这是首次报道 SK3 通道在人子宫 telocyte 中可能发挥作用的证据。